- 13. Cash and cash equivalents
- 14. Trade accounts receivable
- 15. Inventories
- 16. Other current and non-current assets
- 17. Property, plant and equipment
- 18. Goodwill and other intangible assets
- 19. Other accrued expenses
- 20. Other liabilities
- 21. Debt and capital lease obligations
- 22. Senior Notes
- 23. Mandatory Exchangeable Bonds
- 24. Trust preferred securities
- 25. Pensions and similar obligations
- 26. Noncontrolling interest
- 27. Fresenius SE & Co. KGaA shareholders’ equity
- 28. Other comprehensive income (loss)
16. Other current and non-current assets
As of December 31, other current and non-current assets comprised the following:
2011 | 2010 | |||
---|---|---|---|---|
€ in millions | thereof short-term | thereof short-term | ||
Investments and long-term loans | 796 | 9 | 254 | 6 |
Tax receivables | 311 | 287 | 240 | 224 |
Discounts | 143 | 143 | 124 | 124 |
Accounts receivable resulting from German “Krankenhausfinanzierungsgesetz” | 101 | 82 | 111 | 79 |
Capitalized debt financing costs | 98 | 9 | 108 | 10 |
Advances made | 77 | 76 | 53 | 52 |
Leasing receivables | 72 | 29 | 73 | 29 |
Derivative financial instruments | 54 | 52 | 25 | 18 |
Prepaid expenses | 45 | 18 | 45 | 15 |
Re-insurance claims | 11 | 0 | 25 | 0 |
Accounts receivable from management contracts in clinics | 8 | 8 | 7 | 7 |
Other assets | 662 | 478 | 496 | 367 |
Other assets, gross | 2,378 | 1,191 | 1,561 | 931 |
less allowances | 9 | 7 | 8 | 6 |
Other assets, net | 2,369 | 1,184 | 1,553 | 925 |
Investments and long-term loans comprised investments of €537 million (2010: €190 million), mainly regarding the joint venture between Fresenius Medical Care and Galenica Ltd., that were accounted for under the equity method. In 2011, income of €22 million (2010: €4 million) resulting from this valuation was included in general and administrative expenses in the consolidated statement of income. Furthermore, investments and long-term loans include €181 million (2010: €0 million) that Fresenius Medical Care loaned to Renal Advantage Partners, LLC.
The receivables resulting from the German “Krankenhaus- finanzierungsgesetz” primarily contain approved but not yet received earmarked subsidies of the Fresenius Helios operations. The approval is evidenced in a letter written by the granting authorities that Fresenius Helios has already received.
In the fiscal year, the amount of depreciation recognized on other non-current assets was immaterial (2010: €2 million).
15. Inventories
17. Property, plant and equipment